clonidine has been researched along with Disease Exacerbation in 8 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tizanidine is an imidazoline central alpha(2)-adrenoceptor agonist widely used to manage spasticity secondary to conditions such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI)." | 8.84 | A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. ( Henney, HR; Kamen, L; Runyan, JD, 2008) |
| "Tizanidine is an imidazoline central alpha(2)-adrenoceptor agonist widely used to manage spasticity secondary to conditions such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI)." | 4.84 | A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. ( Henney, HR; Kamen, L; Runyan, JD, 2008) |
| " Even when drug-resistance appears to be responsible for the failure to control secondary hypertension in AS, clonidine may represent a safe, effective option in the normalization of high blood pressure." | 3.76 | Ventricular septal defect in a child with Alport syndrome: a case report. ( Bassareo, PP; Marras, AR; Mercuro, G, 2010) |
| "Apraclonidine testing, which is easy to perform and not distressing to the patient, identified PSD in nearly half of DM patients, the degree of mydriasis being correlated to the duration of DM and the presence of DR." | 3.73 | Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients. ( Firat, E; Kansu, T; Kavuncu, S; Koc, F, 2006) |
| "Patients with COPD show higher nicotine dependence and seem to have greater difficulty in quitting smoking." | 2.47 | [Smoking in COPD]. ( Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C, 2011) |
| " The pharmacokinetic analysis was conducted by nonlinear mixed effect modelling, which enables to establish the separate influences of determinants on drug blood level and to provide individualized dosing." | 1.46 | Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration. ( Ahsman, MJ; de Wildt, SN; Kleiber, N; Mathôt, RAA; Tibboel, D; Wildschut, ED, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hyoju, SK | 1 |
| Zaborina, O | 1 |
| van Goor, H | 1 |
| Kleiber, N | 1 |
| Mathôt, RAA | 1 |
| Ahsman, MJ | 1 |
| Wildschut, ED | 1 |
| Tibboel, D | 1 |
| de Wildt, SN | 1 |
| Bassareo, PP | 1 |
| Marras, AR | 1 |
| Mercuro, G | 1 |
| Bruzzone, A | 1 |
| Piñero, CP | 1 |
| Rojas, P | 1 |
| Romanato, M | 1 |
| Gass, H | 1 |
| Lanari, C | 1 |
| Lüthy, IA | 1 |
| Marinkovic, M | 1 |
| Newfield, RS | 1 |
| Zamarro García, C | 1 |
| Bernabé Barrios, MJ | 1 |
| Santamaría Rodríguez, B | 1 |
| Rodríguez Hermosa, JL | 1 |
| Koc, F | 1 |
| Kansu, T | 1 |
| Kavuncu, S | 1 |
| Firat, E | 1 |
| Kamen, L | 1 |
| Henney, HR | 1 |
| Runyan, JD | 1 |
2 reviews available for clonidine and Disease Exacerbation
| Article | Year |
|---|---|
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Ni | 2011 |
A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
Topics: Brain Injuries; Clonidine; Disease Progression; Drug Interactions; Female; Humans; Middle Aged; Mult | 2008 |
6 other studies available for clonidine and Disease Exacerbation
| Article | Year |
|---|---|
SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).
Topics: Antihypertensive Agents; Antiviral Agents; Clonidine; Comorbidity; COVID-19; Disease Progression; Hu | 2020 |
Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.
Topics: Adolescent; Aging; Child; Child, Preschool; Clonidine; Computer Simulation; Disease Progression; Ext | 2017 |
Ventricular septal defect in a child with Alport syndrome: a case report.
Topics: Adrenergic alpha-2 Receptor Agonists; Antihypertensive Agents; Clonidine; Collagen Type IV; Disease | 2010 |
α(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Breast Neopl | 2011 |
Self-limiting hematuria following growth hormone provocative testing with arginine hydrochloride.
Topics: Arginine; Child; Clonidine; Diagnostic Techniques, Endocrine; Disease Progression; Hematuria; Human | 2012 |
Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Clonidine; Diabetic Nephropathies; Disease Progr | 2006 |